Vivo Capital’s Soleno Therapeutics, Inc. Series A Warrant SLNOW Stock Holding History

Vivo Capital’s Portfolio SLNOW Stock Details SLNOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-188,772	Closed	-$19K	–	49
2019 Q2	$19K	Hold	188,772	–	–	﹤0.01%	46
2019 Q1	$28K	Hold	188,772	–	–	﹤0.01%	49
2018 Q4	$19K	Hold	188,772	–	–	﹤0.01%	45
2018 Q3	$23K	Hold	188,772	–	–	﹤0.01%	44
2018 Q2	$79K	Hold	188,772	–	–	0.01%	40
2018 Q1	$23K	Hold	188,772	–	–	﹤0.01%	34
2017 Q4	$27K	Hold	188,772	–	–	0.01%	30
2017 Q3	$112K	Buy	+188,772	New	+$110K	0.02%	29

Vivo Capital's SLNOW Position: Q3 2019 in Review

Vivo Capital sold out of Soleno Therapeutics, Inc. Series A Warrant (SLNOW) in Q3 2019, closing a stake of 188,772 shares — an estimated $19K sold.

Vivo Capital first reported a position in SLNOW in Q3 2017 and held it in 8 quarters. The position peaked at $112K in Q3 2017. 1 fund tracked by Wall St. Rank holds SLNOW as of Q3 2019.

Vivo Capital reported no remaining Soleno Therapeutics, Inc. Series A Warrant position as of Q3 2019 after selling out during the quarter.
Vivo Capital sold 188,772 Soleno Therapeutics, Inc. Series A Warrant shares in Q3 2019, an estimated $19K.
Vivo Capital first reported a position in Soleno Therapeutics, Inc. Series A Warrant in Q3 2017 and held it in 8 quarters.
Vivo Capital's Soleno Therapeutics, Inc. Series A Warrant position peaked at $112K in Q3 2017.
1 fund tracked by Wall St. Rank held Soleno Therapeutics, Inc. Series A Warrant as of Q3 2019.

Based on Vivo Capital's 13F filing for Q3 2019, filed 13 Nov 2019.